The pharmaceutical company says data on 10 deaths and more than 100 hospitalizations comes from the FDA’s adverse event reporting database for semaglutide — the key ingredient in Ozempic and Wegovy, ...
Aetna and OptumHealth agreed to settle a long-running class-action lawsuit over their administration of employee health ...
CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...
CVS did not break out separate enrollment figures for fully insured group health plans when it posted its earnings.
TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The ...
11h
Steve Nelson, a former chief executive officer of UnitedHealthcare, has been named the president of Hartford-based Aetna, ...
CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...
CVS Health shows signs of recovery and growth potential. Learn why CVS stock is a buy with improved cash flow and strong ...
CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...
Lexington Medical Center is trying to negotiate in-network care with Aetna before a February deadline, avoiding a cost hike ...
The move is one of the first from the new CEO, David Joyner, as he looks to repair the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback